Skip to main content
. 2024 Mar 12;2024:8646351. doi: 10.1155/2024/8646351

Table 3.

Safety outcomes.

Outcome Studies Participants Statistical method Effect estimate
GI adverse reactions 6 11575 Odds ratio (Peto, fixed, 95% CI) 1.06 [0.94, 1.20]
Treatment discontinuation 6 11575 Odds ratio (Peto, fixed, 95% CI) 1.11 [0.96, 1.28]
Infections 2 10198 Odds ratio (Peto, fixed, 95% CI) 1.04 [0.84, 1.28]
Myalgia 4 4683 Odds ratio (Peto, fixed, 95% CI) 1.16 [0.99, 1.36]
Cancer 2 10198 Odds ratio R (Peto, fixed, 95% CI) 0.97 [0.78, 1.21]
Myelotoxicity 6 11307 Odds ratio OR (Peto, fixed, 95% CI) 1.01 [0.56, 1.80]